Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 15 of 22
Topical Formulation
Minoxidil 2%w/w is a topical formulation formulated with Minoxidil 2%w/w. The listed active ingredient profile is Minoxidil w/w, placing the product in the hair / scalp treatment category. The formulation contains topical hair/scalp ingredients used in se
Topical Formulation
Minoxidil 5%w/v + Finasteride 0.1%W/ is a topical formulation formulated with Minoxidil 5%w/v + Finasteride 0.1%W/. The listed active ingredient profile is Minoxidil w/v; Finasteride W, placing the product in the hair / scalp treatment category. The formu
Topical Solution
Minoxidil IP 2%w/v Topical Solution is a topical solution formulated with Minoxidil IP 2%w/v. The listed active ingredient profile is Minoxidil w/v, placing the product in the hair / scalp treatment category. The formulation contains topical hair/scalp in
Topical Solution
Minoxidil IP 5%w/v + Aminexil IP 1.5%w/v Topical Solution is a topical solution formulated with Minoxidil IP 5%w/v + Aminexil IP 1.5%w/v. The listed active ingredient profile is Minoxidil w/v; Aminexil w/v, placing the product in the hair / scalp treatmen
Topical Solution
Minoxidil lP 5%w/v Topical Solution is a topical solution formulated with Minoxidil lP 5%w/v. The listed active ingredient profile is Minoxidil lP w/v, placing the product in the hair / scalp treatment category. The formulation contains topical hair/scalp
Topical Formulation
Mometasone Furoate 0.1% w/w is a topical formulation formulated with Mometasone Furoate 0.1% w/w. The listed active ingredient profile is Mometasone Furoate % w/w, placing the product in the topical anti-inflammatory / dermatology category. The formulatio
Topical Formulation
Mometasone Furoate 0.1% w/w + Terbinafine Hydrochloride 1 % w/w is a topical formulation formulated with Mometasone Furoate 0.1% w/w + Terbinafine Hydrochloride 1 % w/w. The listed active ingredient profile is Mometasone Furoate % w/w; Terbinafine Hydroch
Topical Formulation
Mometasone Furoate 0.1%w/w + Fusidic Acld 2%w/w is a topical formulation formulated with Mometasone Furoate 0.1%w/w + Fusidic Acld 2%w/w. The listed active ingredient profile is Mometasone Furoate w/w; Fusidic Acld w/w, placing the product in the topical
Topical Formulation
Mometasone Furoate 0.1%w/w + Terbinafine Hydrochloride 1%ww is a topical formulation formulated with Mometasone Furoate 0.1%w/w + Terbinafine Hydrochloride 1%ww. The listed active ingredient profile is Mometasone Furoate w/w; Terbinafine Hydrochloride ww,
Topical Formulation
Mometasone Furoate 0.3%w/w + Fusidic Acid 2%w/w is a topical formulation formulated with Mometasone Furoate 0.3%w/w + Fusidic Acid 2%w/w. The listed active ingredient profile is Mometasone Furoate w/w; Fusidic Acid w/w, placing the product in the topical
Cream
Mometasone Furoate IP 0.1% + Fusidic Acid IP 2%w/w Cream is a cream formulated with Mometasone Furoate IP 0.1% + Fusidic Acid IP 2%w/w. The listed active ingredient profile is Mometasone Furoate %; Fusidic Acid w/w, placing the product in the topical anti
Cream
Mometasone Furoate IP 0.1%w/w + Terbinafine HCL BP 1%w/w Cream is a cream formulated with Mometasone Furoate IP 0.1%w/w + Terbinafine HCL BP 1%w/w. The listed active ingredient profile is Mometasone Furoate w/w; Terbinafine HCL w/w, placing the product in
Film-Coated Tablet
Moxifloxacin 400 mg Film-Coated Tablet is a film-coated tablet formulated with 400 mg. The active ingredient profile is Moxifloxacin, placing the product in the fluoroquinolone antibiotic category. Moxifloxacin is a fluoroquinolone antibiotic that inhibit
Topical Formulation
Mupirocin 2%w/w + Methyl Paraben 0.16%w/w + Propyl Paraben 0.33./w/w is a topical formulation formulated with Mupirocin 2%w/w + Methyl Paraben 0.16%w/w + Propyl Paraben 0.33./w/w. The listed active ingredient profile is Mupirocin w/w; Methyl Paraben w/w;
Ointment
Mupirocin lp 2%w/w + Methyl Parabe IP 0.16%w/w + Propyl Paraben IP 0.33%w/w Ointment is a ointment formulated with Mupirocin lp 2%w/w + Methyl Parabe IP 0.16%w/w + Propyl Paraben IP 0.33%w/w. The listed active ingredient profile is Mupirocin lp w/w; Methy
Topical Formulation
Nadifloxacin 10 mg is a topical formulation formulated with Nadifloxacin 10 mg. The listed active ingredient profile is Nadifloxacin, placing the product in the topical antibacterial / dermatology category. The formulation contains topical antibacterial i
Film-Coated Tablet
Naproxen 250 mg + Domperidone 10 mg Film-Coated Tablet is a film-coated tablet formulated with Naproxen 250 mg + Domperidone 10 mg. The active ingredient profile is Naproxen; Domperidone, placing the product in the nsaid + antiemetic / prokinetic combinat
Film-Coated Tablet
Naproxen 250 mg Film-Coated Tablet is a film-coated tablet formulated with 250 mg. The active ingredient profile is Naproxen, placing the product in the nsaid / analgesic anti-inflammatory category. The formulation contains an NSAID and/or non-opioid anal
Tablet
Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered) is a tablet formulated with Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered). The listed active ingredient profile is Nebivolol; Cilnidipine, placing the product in the antihypertensive / car
Tablet
Nebivolol Tablets IP 2.5MG (Uncoated) is a tablet formulated with Nebivolol IP 2.5MG ( ). The listed active ingredient profile is Nebivolol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardio
Uncoated Tablet
Nimesulide (in Beta-Cyclodextrin BP) 100 mg Uncoated Tablet is a uncoated tablet formulated with 100 mg. The active ingredient profile is Nimesulide in Beta-Cyclodextrin, placing the product in the nsaid / analgesic anti-inflammatory category. Nimesulide
Uncoated Tablet
Nimesulide 100 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Uncoated Tablet is a uncoated tablet formulated with Nimesulide 100 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Nimesulide; Paracetamol; Chlorzoxazone, plac
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
